Maximus, Inc. (NYSE:MMS – Get Free Report) insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Maximus Trading Down 1.1 %
Shares of Maximus stock opened at $73.84 on Friday. The firm’s 50 day moving average is $85.11 and its 200 day moving average is $87.22. The firm has a market capitalization of $4.45 billion, a PE ratio of 14.77 and a beta of 0.73. Maximus, Inc. has a 1 year low of $71.75 and a 1 year high of $93.97. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.63%. Maximus’s payout ratio is presently 24.00%.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th.
View Our Latest Research Report on MMS
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- 5 Top Rated Dividend Stocks to Consider
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Canada Bond Market Holiday: How to Invest and Trade
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.